Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.078 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.069 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |